KR900012613A - 경구 투여용 의약조성물 - Google Patents

경구 투여용 의약조성물 Download PDF

Info

Publication number
KR900012613A
KR900012613A KR1019890001737A KR890001737A KR900012613A KR 900012613 A KR900012613 A KR 900012613A KR 1019890001737 A KR1019890001737 A KR 1019890001737A KR 890001737 A KR890001737 A KR 890001737A KR 900012613 A KR900012613 A KR 900012613A
Authority
KR
South Korea
Prior art keywords
composition
oral administration
vitamin
active ingredient
pharmaceutical composition
Prior art date
Application number
KR1019890001737A
Other languages
English (en)
Other versions
KR910004482B1 (ko
Inventor
선종진
Original Assignee
선종진
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 선종진 filed Critical 선종진
Priority to KR1019890001737A priority Critical patent/KR910004482B1/ko
Publication of KR900012613A publication Critical patent/KR900012613A/ko
Application granted granted Critical
Publication of KR910004482B1 publication Critical patent/KR910004482B1/ko

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

내용 없음

Description

경구 투여용 의약조성물
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (6)

  1. 고체상 에멀죤을 형성하는 부형제에 오일상의 점조한 유효성분을 담지시켜서된 경구투여용 의약조성물.
  2. 청구범위 1항에서, 유효성분이 비타민 A 또는 비타민 E임을 특징으로 하는 조성물.
  3. 청구범위 1항에서, 조성물이 티피드 피복물질, 수용성 피복물질 전소화 효소, 유화제 계면 활성제 및 항미생물제를 포함함을 특징으로 하는 조성물.
  4. 청구범위 1항에서, 조성물이 캡슐 또는 정제 형태로 제제됨을 특징으로 하는 조성물.
  5. 청구범위 1항에서, 조성물이 물과 접촉하여 액상 에멀죤을 형성함을 특징으로 하는 조성물.
  6. 청구범위 1항에서, 조성물이 유효성분과 함께 올레인산트립신, 담즙염, 염화칼슘, 메틸파레벤류, 솔리톨, 비이검, 구연산 또는 구연산 나트륨라우릴설페이트, 하이드록시프로필셀룰로우스, 하이드록시프로필메틸폴리에틸렌 글리콜지방산 에스텔을 포함함을 특징으로 하는 조성물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019890001737A 1989-02-15 1989-02-15 경구투여용 의약 조성물 KR910004482B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019890001737A KR910004482B1 (ko) 1989-02-15 1989-02-15 경구투여용 의약 조성물

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019890001737A KR910004482B1 (ko) 1989-02-15 1989-02-15 경구투여용 의약 조성물

Publications (2)

Publication Number Publication Date
KR900012613A true KR900012613A (ko) 1990-09-01
KR910004482B1 KR910004482B1 (ko) 1991-06-29

Family

ID=19283821

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890001737A KR910004482B1 (ko) 1989-02-15 1989-02-15 경구투여용 의약 조성물

Country Status (1)

Country Link
KR (1) KR910004482B1 (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10160358A1 (de) * 2001-12-08 2003-06-18 Degussa Verfahren zur Herstellung von Methionin

Also Published As

Publication number Publication date
KR910004482B1 (ko) 1991-06-29

Similar Documents

Publication Publication Date Title
KR870002835A (ko) 이온화성 소수성약제의 약제학적 제조방법
NO995367L (no) Aktivert Vitamin D3-emulsjonstype losjoner
KR950007841A (ko) 트라마돌 염을 함유하는 서방성 약물 제제
ATE307569T1 (de) Gelierbare pharmazeutische zusammensetzungen
EP0287322A3 (en) Stable pharmaceutical w/o emulsion composition
DE3750369D1 (de) Arzneimittelzusammensetzungen.
DK0904064T3 (da) Orale farmaceutiske præparater indeholdende kønshormoner
DE59008336D1 (de) Orale Lipidarzneiform.
EE05072B1 (et) Farmatseutilised kompositsioonid limaskestale kandmiseks
ATE334689T1 (de) Verabreichungsmedium für analgetische, entzündungshemmende und antipyretische wirkstoffe und pharmazeutische zusammensetzungen enthaltend solches medium und wirkstoffe
BE899635A (fr) Compositions pharmaceutiques.
BR9706537A (pt) Composição farmacêutica para administração por via oral
ATE311177T1 (de) Orale pharmazeutische zusammensetzungen, die langkettige triglyceride und lipophile tenside enthalten
KR920702216A (ko) 아세틸 d-카르니틴의 녹내장 치료에의 용도
RS50373B (sr) Čvrste lipidne smeše
BR9809571A (pt) Composição medicinal e processo para produzì-la
KR900012613A (ko) 경구 투여용 의약조성물
FR2363324A1 (fr) Solutions aqueuses ou hydroalcooliques stables d'essences parfumees ou de medicaments solubles dans l'huile
KR890011594A (ko) 4-아로일이미다졸-2-온의 제약 조성물
KR900701254A (ko) 정제 가능한 제제 및 이것으로 만들어진 정제
ATE301453T1 (de) Injizierbare arzneiformulierungen von partricin derivaten
KR830000048A (ko) 서방출형 제제의 제조방법
KR920019343A (ko) α-리놀렌산을 이용한 혈관질환 예방 및 치료제 조성물
KR920000316A (ko) 젬피브로질 제제
KR920019344A (ko) α-리놀렌산을 이용한 간장질환의 예방 및 치료 조성물

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19940620

Year of fee payment: 4

LAPS Lapse due to unpaid annual fee